IL-10 antibody
Quick Overview for IL-10 antibody (ABIN7605245)
Target
See all IL-10 (IL10) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-IL10 Monoclonal Antibody
-
Characteristics
- Anti-IL10 Monoclonal Antibody (ABIN7605245). Tested in WB, ICC/IF, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human IL10 Interleukin-10 (IL-10) is an anti-inflammatory cytokine that is produced by T cells, NK cells, and macrophages. IL-10 initiates signal transduction by binding to a cell surface receptor complex consisting of IL-10 RI and IL-10 RII, leading to the activation of Jak1 and Tyk2 and phosphorylation of Stat3.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:500-1:2000
ICC/IF 1:50-1:200
FC 1:50 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
-
Concentration
- Lot specific
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
-
-
- IL-10 (IL10) (Interleukin 10 (IL10))
-
Alternative Name
- IL10
-
Background
-
Synonyms: Signal transducer and activator of transcription 3,Acute-phase response factor,STAT3,APRF,
Tissue Specificity: Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
-
Molecular Weight
- 17 kDa
-
UniProt
- P22301
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
Target
-